Latest News
NewsLatest News
TIANS group joins hands with Vogel biopharmaceutical technology exchange to help healthy China
source:TIANS
date:2021-04-01

[Abstract]:

On March 30, the 2021 fergo biopharmaceutical technology exchange meeting with the theme of "innovation, efficiency and compliance" was held in Suzhou. TIANS group was invited to participate, and Qiu Jifu, chief engineer of Shanghai Design and Research Institute of TIANS group, was invited to share "Discussion on HVAC design points of monoclonal antibody drug production facilities" at the forum of "biopharmaceutical engineering and equipment".

 

The conference was jointly held by the industry leading media mechanic fergo, its pharmaceutical industry magazine and Suzhou biomedical industrial park. Experts from domestic and foreign pharmaceutical regulatory agencies, experts from biopharmaceutical industry, and directors of R & D, production, quality control, engineering and facility management of Biopharmaceutical Enterprises were invited to discuss policies and regulations, process technology, cost saving, facilities, equipment and supply In order to help Biopharmaceutical Enterprises to solve the pain point problems in R & D, production and supply chain of innovative biopharmaceuticals, case and practical experience sharing should be carried out.

1、 A special report on a master of ingenuity

Starting from the process characteristics of monoclonal antibody drugs, combined with the latest experience in the design and construction of monoclonal antibody plant facilities, Qiu Jifu elaborated the main technical measures and commonly used energy-saving measures in HVAC design of monoclonal antibody drug production facilities. The participants had a deeper understanding of the HVAC design and construction of the McAb plant, which promoted the construction and expansion of TIANS technology brand.

 

2、 The industry leads the scene style of TIANS

This meeting focused on the biological industry. More than 300 professionals from famous Biopharmaceutical Enterprises, such as Baiji Shenzhou, Kaifa pharmaceutical, Jiangsu Taikang biological, Baifan biological, etc., attended the meeting, and carried out discussions and exchanges with technical experts of TIANS group in various aspects, so as to achieve mutual understanding and trust.Through the understanding of several biomedical projects and strength designed and constructed by the group, such as Maiwei biology, Junshi biology, Heyuan biology, Hengrun Dasheng, we have deepened our brand awareness of one-stop solution providers for the construction of TIANS biomedical engineering facilities.

 

In the future, the group will continue to provide exclusive customized solutions and brand-new design and construction ideas as its goal on the road of pharmaceutical EPC mode, and contribute "all the time wisdom" to the development of pharmaceutical enterprises.